SLC7A11 and type 1 diabetes mellitus: Notably, OE‐SLC7A11 treatment effectively restored glutathione homeostasis, increasing GSH levels, the GSH/GSSG ratio, total glutathione, and decreasing GSSG levels compared to T1DM + 6‐OHDA rats without SLC7A11 overexpression.